- Home
- RDHL vs DKI Comparison
RDHL vs DKI Comparison
Compare RDHL & DKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RDHL | DKI |
|---|---|---|
| Founded | 2009 | 2018 |
| Country | Israel | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 6.2M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | RDHL | DKI |
|---|---|---|
| Price | $1.36 | $0.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 158.0K |
| Earning Date | 09-05-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 26.19 |
| Revenue | $9,550,000.00 | ★ $10,204,329.00 |
| Revenue This Year | $381.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.01 |
| Revenue Growth | ★ 157.62 | 100.46 |
| 52 Week Low | $0.91 | $0.30 |
| 52 Week High | $6.80 | $15.00 |
Technical Indicators
Market Signals| Indicator | RDHL | DKI |
|---|---|---|
| Relative Strength Index (RSI) | 57.48 | N/A |
| Support Level | $1.20 | N/A |
| Resistance Level | $1.38 | N/A |
| Average True Range (ATR) | 0.11 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 82.54 | 0.00 |
Price Performance
Historical ComparisonAbout RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About DKI DarkIris Inc. Class A Ordinary Shares
Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.